We have an exciting opportunity for a Consultant Chemical Pathologist and invite applications from suitably qualified and experienced candidates with significant experience of working in a busy Chemical Pathology Department.
We are seeking an outstanding clinician who is also an established, or potential future leader for Chemical Pathology services at Maidstone and Tunbridge Wells NHS Trust. This is a full-time (10 PA) replacement consultant post.
The post-holder will join a senior Chemical Pathology team. The MTW establishment comprises 2 medical consultant chemical pathologist and 4.11 WTE clinical scientists. The post holder will ultimately provide comprehensive Chemical Pathology / Clinical Biochemistry services for MTW.
This post will be based at Tunbridge Wells hospital, however cross cover will be expected for the current MTW sites there is a good degree of collaborative working between sites.
Clinical, scientific and associated duties:
• Provision of clinical lipid services
• Clinical liaison with service users
• Maintain high-quality service and UKAS accreditation
• Contribute to the development of networked pathology solutions in the region
The Trust was formed in April 2000 by the merger of the Mid Kent Healthcare Trust and the Kent & Sussex Weald NHS Trust. It provides general hospital services to a population of approximately 460,000 in West Kent and North East Sussex, and some specialist services to a considerably larger population. Its major hospitals are the Tunbridge Wells Hospital at Pembury and Maidstone Hospital. The Trust’s Headquarters are at Maidstone Hospital. The Trust’s Chairman is Mr David Highton, the Chief Executive is Mr Miles Scott and the Medical Director is Dr Peter Maskell. Clinical services are organised into nine Directorates.
MTW are part of Pathology Network South 8, along with East Kent Hospital University Foundation NHS Trust (EKHUFT), Dartford and Gravesham NHS Trust, Medway NHS Foundation Trust. There are a number of strategic workstreams forming to drive harmonisation and centralisation across the network. It would be expected that the postholder plays an active role in moving forward these network links and sits on Biochemistry working parties.
The MTW laboratories are currently accredited with UKAS against ISO 15189, with a recent successful UKAS inspection. The Chemistry Department currently processes around 1.6m request/ 8 million tests per year.
The post holder will provide a comprehensive Chemical Pathology service for all users of the laboratory, in conjunction with their consultant and clinical scientist colleagues.
The post holder will provide expert support for the diagnosis and management of biochemical clinical problems, advise on appropriate investigations on an individual patient basis and determine the repertoire provide by the Chemical Pathology department within the resources available to the directorate. The post holder will provide clinical leadership and supervision of all aspects of the laboratories’ undertakings. This will include line-management and appraisal for the Clinical Scientific Staff.
The post holder will work in close partnership with the full-time consultant based at MTW and the group of clinical scientists. The post holder will have authorisation for access to the MTW network and LIMS in order, to be able to authorise results remotely when required.
The clinical service includes an existing lipid clinic, with the opportunity to develop these and other clinical services further in conjunction with clinical teams at either site, on the basis of service demands and the experience and expertise of the individual.
The post holder will take a lead role in clinical liaison and clinical audit.
Recognising the national drive towards further development of Pathology networking in England, as set out by NHS Improvement in September 2017, the post holder must have attributes, skills and experience that will make a positive contribution to collaborative working across the proposed network for Kent and Medway.
The post holder will have a commitment to teaching of both undergraduates and postgraduates and will be expected to participate in clinical teaching of undergraduate and junior medical staff within their supporting Professional Activities as required by the Clinical Unit. If there is a specific interest or need, a more extensive teaching role can be developed within the Clinical Unit structure and under the direction of the Specialty College Tutor.
Research and Development are fundamental to patient safety. Research and development activities are an important use of supporting professional activity time. Any time within job plans allocated to R&D should be evidenced in terms of agreed high quality outputs and linking to personal objectives around appraisal.
The post holder will be encouraged to develop clinical research activity according to their academic interests. The MTW and MTW Trust Boards recognise the importance of clinical research to the provision of safe, high quality, responsive clinical care. They are committed to maximising opportunities for patients to participate in research, and to fostering an environment in which clinical academic activity thrives. Numerous academic and commercial trials and observational studies are in progress at MTW and a dedicated Clinical Investigation and Research Unit is available at MTW. Collaborative research relationships within regional and national specialist networks and societies, e.g., Association for Clinical Biochemistry, Society for Endocrinology, NIHR CRN: Kent, Surrey & Sussex, will be encouraged.
Clinical trials and other research are managed by the Research and Development teams at MTW. As an employee of MTW you will be required to comply with all reporting requirements systems and duties of action put in place by the Trust to deliver Research Governance Standards. From time to time during the normal course of your employment you may generate Intellectual Property, which may have value in the delivery of better patient care. Where such IP is created in the course of your employment or normal duties then under UK law it will generally belong to the Trust unless otherwise agreed in writing between you and the Trust.
The Trust management procedures for intellectual property (IP) have been approved by the Trust Board and can be found on the Trust Intranet Site. Trust Procedures are consistent with the Management Framework for IP of the Department of Health. You will be required to comply with these procedures. All bids for research should be worked up in conjunction with the Pathology Executive Team. All NHS Support Costs and Research Costs must be fully funded before projects are started, either by external sources or via the NHS R&D funding schemes. Formal confirmation of Trust approval, facilitated by the Trust R&D office, will be required before proceeding.
Evidence of CME participation will become part of the postholders portfolio. Visits to other hospitals and working with colleagues are encouraged as an important part of CPD.